These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281 [TBL] [Abstract][Full Text] [Related]
23. Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells. Vella S; Conti M; Tasso R; Cancedda R; Pagano A Int J Cancer; 2012 Apr; 130(7):1484-93. PubMed ID: 21557214 [TBL] [Abstract][Full Text] [Related]
24. Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation. Zhou X; Chen R; Yu Z; Li R; Li J; Zhao X; Song S; Liu J; Huang G Mol Cancer; 2015 Mar; 14():63. PubMed ID: 25888721 [TBL] [Abstract][Full Text] [Related]
25. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A; Kant S; Singh SM Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182 [TBL] [Abstract][Full Text] [Related]
26. Developing new anti-cancer drugs. Pereira Rde S Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):1-5. PubMed ID: 21110819 [No Abstract] [Full Text] [Related]
27. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells. Choi YW; Lim IK Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191 [TBL] [Abstract][Full Text] [Related]
28. Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism. Duncan GE; Perkins LA; Theriaque DW; Neiberger RE; Stacpoole PW J Clin Endocrinol Metab; 2004 Apr; 89(4):1733-8. PubMed ID: 15070938 [TBL] [Abstract][Full Text] [Related]
29. Latent carcinogenicity of early-life exposure to dichloroacetic acid in mice. Wood CE; Hester SD; Chorley BN; Carswell G; George MH; Ward W; Vallanat B; Ren H; Fisher A; Lake AD; Okerberg CV; Gaillard ET; Moore TM; Deangelo AB Carcinogenesis; 2015 Jul; 36(7):782-91. PubMed ID: 25913432 [TBL] [Abstract][Full Text] [Related]
30. Effect of pretreatment with dichloroacetate or trichloroacetate on the metabolism of bromodichloroacetate. Austin EW; Bull RJ J Toxicol Environ Health; 1997 Nov; 52(4):367-83. PubMed ID: 9354181 [TBL] [Abstract][Full Text] [Related]
31. In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Fuscoe JC; Afshari AJ; George MH; DeAngelo AB; Tice RR; Salman T; Allen JW Environ Mol Mutagen; 1996; 27(1):1-9. PubMed ID: 8625942 [TBL] [Abstract][Full Text] [Related]
32. Use of oral dichloroacetate for palliation of leg pain arising from metastatic poorly differentiated carcinoma: a case report. Khan A J Palliat Med; 2011 Aug; 14(8):973-7. PubMed ID: 21486148 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Antitumor Effects of Combined and Separate Treatment with NO Synthase Inhibitor T1023 and PDK1 Inhibitor Dichloroacetate. Filimonova MV; Podosinnikova TS; Samsonova AS; Makarchuk VM; Shevchenko LI; Filimonov AS Bull Exp Biol Med; 2019 Nov; 168(1):92-94. PubMed ID: 31768777 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial metabolism - neglected link of cancer transformation and treatment. Pokorný J; Jandová A; Nedbalová M; Jelínek F; Cifra M; Kučera O; Havelka D; Vrba J; Vrba J; Coček A; Kobilková J Prague Med Rep; 2012; 113(2):81-94. PubMed ID: 22691280 [TBL] [Abstract][Full Text] [Related]
36. Reduction in spinal cord postischemic lactic acidosis and functional improvement with dichloroacetate. Robertson CS; Goodman JC; Grossman RG; Priessman A J Neurotrauma; 1990; 7(1):1-12. PubMed ID: 2342114 [TBL] [Abstract][Full Text] [Related]
37. DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft. Zheng MF; Shen SY; Huang WD Cancer Chemother Pharmacol; 2013 Nov; 72(5):1031-41. PubMed ID: 24043136 [TBL] [Abstract][Full Text] [Related]
38. Development of a dichloroacetic acid-hemoglobin conjugate as a potential targeted anti-cancer therapeutic. Zhang N; Palmer AF Biotechnol Bioeng; 2011 Jun; 108(6):1413-20. PubMed ID: 21328317 [TBL] [Abstract][Full Text] [Related]
39. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Stauber AJ; Bull RJ Toxicol Appl Pharmacol; 1997 Jun; 144(2):235-46. PubMed ID: 9194407 [TBL] [Abstract][Full Text] [Related]
40. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Stauber AJ; Bull RJ; Thrall BD Toxicol Appl Pharmacol; 1998 Jun; 150(2):287-94. PubMed ID: 9653059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]